Post

Boehringer’s weight loss jab as good as Wegovy but not Zepbound

Boehringer Ingelheim’s (BI’s) weight loss jab has shown similar efficacy to Wegovy (semaglutide) but a strength inferior to Zebound (tirzepatide). The …
Meta-analysis backs broader use of BP therapy in CKD

A recent study conducted by Guyu Zeng and colleagues and published in The Lancet highlighted that lowering blood pressure (BP) …
The strategic investments expanding CDMO capabilities for HPAPIs and ADCs

As oncology pipelines continue to expand and targeted therapies become more sophisticated, contract development and manufacturing organisations (CDMOs) must invest …
FDA launches pilot for real-time clinical trials

The US Food and Drug Administration (FDA) is launching a pilot to implement real-time clinical trials (RTCT). While announcing the pilot, …
Argo Biopharma begins dosing for Phase I BW-50218 trial

Argo Biopharmaceutical (Argo Biopharma) has dosed the first subject in its Phase I clinical trial assessing BW-50218, a small-interfering ribonucleic …

Precision begins patient enrolment for FUNCTION-DMD trial

Precision BioSciences has activated Arkansas Children’s Hospital as the first site and initiated patient enrolment for its Phase I/II FUNCTION-DMD …
Boehringer’s weight loss jab as good as Wegovy but not Zepbound

Boehringer Ingelheim’s (BI’s) weight loss jab has shown similar efficacy to Wegovy (semaglutide) but a strength inferior to Zebound (tirzepatide). The …
Meta-analysis backs broader use of BP therapy in CKD

A recent study conducted by Guyu Zeng and colleagues and published in The Lancet highlighted that lowering blood pressure (BP) …
The strategic investments expanding CDMO capabilities for HPAPIs and ADCs

As oncology pipelines continue to expand and targeted therapies become more sophisticated, contract development and manufacturing organisations (CDMOs) must invest …
FDA launches pilot for real-time clinical trials

The US Food and Drug Administration (FDA) is launching a pilot to implement real-time clinical trials (RTCT). While announcing the pilot, …
Argo Biopharma begins dosing for Phase I BW-50218 trial

Argo Biopharmaceutical (Argo Biopharma) has dosed the first subject in its Phase I clinical trial assessing BW-50218, a small-interfering ribonucleic …
EnteroBiotix nets $25m to progress microbiome-based IBS drug

Investors have gone with their gut on EnteroBiotix’s microbiome-based lead therapy, EBX-102-02, pledging £19m ($25m) to fund a mid-stage trial …
Massive Bio partners with OpenAI to broaden clinical trial access

Massive Bio has entered a partnership with OpenAI to expand global access to clinical studies through AI-driven parameterisation of protocols …
Veradermics’ stock grows on pivotal hair loss win

Veradermics’ share price has jumped more than 47% after its oral, extended-release version of minoxidil posted a win during a …
Compass Therapeutics’s stock crashes after OS miss in BTC trial

Compass Therapeutics’ stock has dropped by more than 60% after a Phase II/III trial of its biliary tract cancer (BTC) …